MedPath

Meiji Pharma USA Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:1

Trial Phases

1 Phases

Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 2
1 (100.0%)

Efficacy and Safety of ME3183 in Subjects With Moderate to Severe Plaque Psoriasis

Phase 2
Completed
Conditions
Plaque Psoriasis
Interventions
Drug: Placebo
First Posted Date
2022-03-07
Last Posted Date
2024-06-27
Lead Sponsor
Meiji Pharma USA Inc.
Target Recruit Count
132
Registration Number
NCT05268016
Locations
🇺🇸

Northwest Arkansas Clinical Trials Center, Rogers, Arkansas, United States

🇺🇸

University of Southern California, Los Angeles, California, United States

🇺🇸

Colorado Medical Research Center, Inc., Denver, Colorado, United States

and more 24 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.